Trillium Therapeutics Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Trillium Therapeutics Inc.
CIK #0001616212
EDGAR Form CIK 2011 - 2025
10-K [0001616212]
10-Q [0001616212]
3 [0001616212]
4 [0001616212]
6-K [0001616212]
8-K [0001616212]
D [0001616212]
SC 13D [0001616212]
SC 13G [0001616212]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP Trillium Therapeutics Inc [2021-02-16]
Avoro Capital Advisors LLC Trillium Therapeutics Inc [2021-02-12]
SIO Capital Management LLC Trillium Therapeutics Inc [2020-02-14]
Boxer Capital LLC Trillium Therapeutics Inc [2020-02-03]
Vivo Capital IX LLC Trillium Therapeutics Inc [2020-02-03]
Venrock Healthcare Capital Partners III LP Trillium Therapeutics Inc [2020-01-21]
Morgan Stanley Trillium Therapeutics Inc [2019-12-31]
Empery Asset Management LP Trillium Therapeutics Inc [2019-03-04]
Morgan Stanley Trillium Therapeutics Inc [2018-12-21]
AWM Investment Company Inc Trillium Therapeutics Inc [2018-02-13]
View All
Form 3/4/5 Subject 2011 - 2025
Skvarka Jan
Trillium Therapeutics Inc.
Walker Paul Edward
Pucci Paolo
Myers Scott Dunseth
Harrison Rosemary
Beshar Luke M
Parsons James T.
Kamarck Michael E.
Looker Benjamin
View All
Terms | Privacy | Guide
tony@aum13f.com